The Economics of Orphan Drug Policy in the US John W. PeabodyAllen RubyPeter Cannon Leading Article 25 November 2012 Pages: 374 - 384
Cost Effectiveness of Antituberculosis Interventions Adauto CasteloPedro A. MathiasiMichael Drummond Review Article 25 November 2012 Pages: 385 - 399
The Economic Effects of Introducing Vigabatrin, a New Antiepileptic Medication Daniel ReinharzWendy KennedyFrançois Champagne Original Research Article 25 November 2012 Pages: 400 - 409
The Cost Effectiveness of Helicobacter pylori Eradication versus Maintenance and Episodic Treatment in Duodenal Ulcer Patients in Sweden Peter UngeBengt JönssonNils-Olov Stålhammar Original Research Article 25 November 2012 Pages: 410 - 427
Alteplase Lee B. BarradellKaren L. Goa Pharmacoeconomic Drug Evaluation 25 November 2012 Pages: 428 - 459